Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can better advice cut infections after lung transplants?

NCT ID NCT07788417

Knowledge-focused Sponsor: Fondation Hôpital Saint-Joseph Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Sep 01, 2026 · Updated 3 times

Summary

This study looks at the infection-prevention advice given to people who have had a lung or heart-lung transplant. Researchers will survey patients and healthcare professionals to see what recommendations are made, how well patients follow them, and where gaps exist. The goal is to understand current practices and potentially harmonize guidance to reduce infection risks and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to more consistent, evidence-based infection-prevention advice for transplant patients, potentially reducing infections and improving quality of life.
What could go wrong
This is an observational study, so it cannot prove cause and effect. The findings may not apply to all transplant types, and patient-reported behaviors may not reflect actual adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients who have received a lung transplant or a heart-lung transplant.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient aged 18 years or older at the time of transplantation * French-speaking patient * Patient who has undergone a lung transplantation or a heart-lung transplantation Exclusion Criteria: * Patients under legal guardianship or curatorship * Patients deprived of their liberty * Patients subject to a judicial protection measure (safeguard of justice) * Patients who object to the use of their data for the purposes of this study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pulmonary transplantation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pulmonary transplantation Transplantation infection

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHRU Strasbourg

    Strasbourg, France

  • Groupe Hospitalier Paris Saint-Joseph

    Paris, Groupe Hospitalier Paris Saint-Joseph, 75014, France

  • Hôpital Bichat

    Paris, France

  • Hôpital Foch

    Suresnes, France

  • Hôpital Haut-Lévêque-Pessac, Bordeaux

    Bordeaux, France

  • Hôpital Louis Pradel - Lyon

    Lyon, France

  • Hôpital Nord - Marseille

    Marseille, France

  • Hôpital Nord Saint-Herblain- Nantes

    Nantes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.